Grauer & Weil (India) Limited (NSE:GRAUWEIL)
76.55
+1.24 (1.65%)
Nov 11, 2026, 1:16 PM IST
Grauer & Weil (India) Revenue
Grauer & Weil (India) had revenue of 3.38B INR in the quarter ending September 30, 2026, with 16.02% growth. This brings the company's total for the last twelve months to 12.71B, up 9.57% year-over-year. In the fiscal year ending March 31, 2026, Grauer & Weil (India) had annual revenue of 11.91B with 4.99% growth.
Revenue (ttm)
12.71B
Revenue Growth
+9.57%
P/S Ratio
2.73
Revenue / Employee
13.61M
Employees
934
Market Cap
34.68B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full Grauer & Weil (India) breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 11.91B | 566.42M | 4.99% |
| Mar 31, 2025 | 11.34B | 646.92M | 6.05% |
| Mar 31, 2024 | 10.70B | 871.42M | 8.87% |
| Mar 31, 2023 | 9.83B | 2.13B | 27.62% |
| Mar 31, 2022 | 7.70B | 1.63B | 26.80% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Savita Oil Technologies | 54.87B |
| Laxmi Organic Industries | 35.02B |
| Rossari Biotech | 26.61B |
| Veedol Corporation | 24.01B |
| Jubilant Agri and Consumer Products | 20.52B |
| Indigo Paints | 15.13B |
| Prasol Chemicals | 14.66B |
| Advanced Enzyme Technologies | 7.82B |